In vitro Measured Indoleamine 2, 3-dioxygenase Activity Correlates with Inflammation and Tryptophan Levels In vivo
Journal Title: International Neuropsychiatric Disease Journal - Year 2014, Vol 2, Issue 5
Abstract
Aims: To evaluate the diagnostic validity of an in vitro assay for indoleamine 2,3-dioxygenase (IDO) activity as indicator for biological alterations that are associated with depressive symptomatologies. Study Design: Retrospective evaluation of a medical database. Place and Duration of Study: Institute for Medical Diagnostics, Berlin, between April and July 2013. Methodology: We compared values for IDOin vitro, a so far unpublished assay for IDO activity that measures tryptophan degradation in peripheral blood monocytic cell (PBMC), with blood levels of tryptophan and tumor necrosis factor alpha (TNF-alpha). Values were derived from a clinical database comprising 441 patients who had received IDOin vitro, tryptophan and/or TNF-alpha testing in the course of medical treatment between May 2011 and March 2013. All data was anonymized. Clinical significance of IDOin vitro was evaluated by correlation of IDOin vitro to blood tryptophan and TNF-alpha α levels. Further, we challenged the validity of the IDOin vitro assay by investigating the influence of the PBMC proliferation rate as a potential confounding factor and comparing the responses to phythemagglutinin (PHA) and interferon-gamma (IFN-gamma), a recognized inducer of IDO activity. Results: Low plasma tryptophan and high serum TNF-alpha are associated with increased IDOin vitro (2.8±3.3 vs. 2.2±1.1, P=0.04 and 2.7±3.5 vs. 2.1±1.6, P=0.05). Elevated IDOin vitro is not due to increased PBMC proliferation rates. PHA and IFN-gamma yield correlating IDOin vitro values (correlation coefficient=0.91). Conclusions: IDOin vitro represents a valid diagnostic tool for IDO activity and correlates with inflammation and decreased availability of tryptophan in vivo. IDOin vitro may therefore serve as a biomarker to examine the interaction of inflammation and tryptophan metabolism that underlies a subgroup of depressive symptomatologies.
Authors and Affiliations
Katrin Huesker, Jana Schenk, Stefan Albrecht, Imad Lahdou, Volker von Baehr
Keywords
Related Articles
- EP ID EP241541
- DOI 10.9734/INDJ/2014/9065
- Views 132
- Downloads 0
Investigating the Frequency and Association of BACE1-AS rs147542312C/T with Alzheimer's Disease in Northwest of Iran
Background and Aims: Alzheimer’s disease is the most common neurodegenerative disorder worldwide. The long noncoding RNA, BACE1-AS, acts as a regulator of BACE1 transcript which its product involves in Alzheimer’s diseas...
Therapeutic Serum Concentration Measurement of Oxcarbazepine in Epilepsy Patient
Aim: To study measurement of the therapeutic serum concentration of Oxcarbazepine (OXC) in children diagnosed with epilepsy and to analyze the relationship among the serum drug concentration of OXC based on drug dose/wei...
Bromocriptine Mesylate Protects against Status Epilepticus and Temporal Lobe Epilepsy: Neurobehavioral, Histopathological and Neurochemical Evidences
Background: Dopamine (DA) plays a major role in the control of epileptic seizures arising in the limbic system, through D1/D2 receptor-mediated signaling. Objective: The study was intended to investigate whether bromocr...
Behavioral and Psychological Symptoms of Dementia in Nigerian Hospital Patients: Prevalence, Correlates and Caregiver Burden
Aims: This study was aimed at measuring the prevalence and impact of Behavioral and Psychological Symptoms of Dementia (BPSD) of elderly hospital attendees in Lagos Nigeria; and determining socio-cultural factors associa...
Social Support after Stroke: Influence of Source of Support on Stroke Survivors’ Health-Related Quality of Life
Introduction: Social support has often been identified as a key determinant of important stroke outcomes such as health-related quality of life (HRQoL). Information on the influence of the specific sources of social supp...